NSERecord Date1 Jul 2026 · 1 Jul 2026, 12:44 pm

Record Date

Windlas Biotech Limited · WINDLAS

✦ AI SummaryDividend

Windlas Biotech Limited has announced the record date for the purpose of dividend for the financial year 2025-26 as July 16, 2026, and has recommended a dividend of Rs. 6.30 per equity share.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Windlas Biotech Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Jul-2026.

Attachments (1)

📄

WINDLAS_01072026124322_Record_Date_16072026.pdf

pdf

Download →
View document text
Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 July 1, 2026 To To Listing / Compliance Department Listing / Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 051 BSE CODE: 543329 NSE SYMBOL: WINDLAS Dear Sir/ Madam, Sub: Intimation of 25th Annual General Meeting and Record Date We wish to inform you that the 25th Annual General Meeting (AGM) of the Company is scheduled to be held on Thursday, July 23, 2026 at 1.00 p.m. (IST) through Video Conferencing / Other Audio Visual Means. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Thursday, July 16, 2026, as the Record Date for the purpose of determining the members eligible to receive dividend for the financial year 2025-26. As informed earlier, the Board has recommended a dividend of Rs. 6.30/- per equity share i.e @126% on the face value of equity share of Rs. 5/- each for the financial year 2025-26, subject to approval of the shareholders at the 25th AGM. The dividend shall be subject to deduction of tax at source. This is for your kind information and record. Thanking you, Yours faithfully, For Windlas Biotech Limited Ananta Narayan Panda Company Secretary & Compliance Officer www.windlas.com